Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemens-Martin Wendtner

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Emerging Infectious Diseases|March 25, 2014
Contact investigation for imported case of Middle East respiratory syndrome, GermanyAnnicka Reuss, Annette Litterst, Christian Drosten, et al.
Blood|August 29, 2012
B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramidesJanine Schwamb, Valeska Feldhaus, Michael Baumann, et al.
Leukemia Research|December 15, 2012
Evaluation of the proposed reporting system of the European LeukemiaNet and recommendations for prognosis of acute myeloid leukemiaTamara Alpermann, Wolfgang Kern, Susanne Schnittger, et al.
Oncology|March 9, 2007
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomasMarcus Schlemmer, Clemens-Martin Wendtner, Martin Falk, et al.
Leukemia Research|January 23, 2010
Erufosine, a novel alkylphosphocholine, induces apoptosis in CLL through a caspase-dependent pathwaySonja Katharina Königs, Christian Philipp Pallasch, Lars Hartwin Lindner, et al.
American Journal of Hematology|May 29, 2021
Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trialOthman Al-Sawaf, Brittany Gentile, Jacob Devine, et al.
Blood|August 15, 2002
Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectorsClemens-Martin Wendtner, David M Kofler, Hans D Theiss, et al.
Blood|February 12, 2015
miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLLValeska Berg, Marion Rusch, Nachiket Vartak, et al.
Leukemia & Lymphoma|July 1, 2016
FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemiaNadine Kutsch, Raymonde Busch, Jasmin Bahlo, et al.
Blood|August 24, 2012
A novel hierarchical prognostic model of AML solely based on molecular mutationsVera Grossmann, Susanne Schnittger, Alexander Kohlmann, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Emerging Infectious Diseases|March 25, 2014
Contact investigation for imported case of Middle East respiratory syndrome, GermanyAnnicka Reuss, Annette Litterst, Christian Drosten, et al.
Blood|August 29, 2012
B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramidesJanine Schwamb, Valeska Feldhaus, Michael Baumann, et al.
Leukemia Research|December 15, 2012
Evaluation of the proposed reporting system of the European LeukemiaNet and recommendations for prognosis of acute myeloid leukemiaTamara Alpermann, Wolfgang Kern, Susanne Schnittger, et al.
Oncology|March 9, 2007
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomasMarcus Schlemmer, Clemens-Martin Wendtner, Martin Falk, et al.
Leukemia Research|January 23, 2010
Erufosine, a novel alkylphosphocholine, induces apoptosis in CLL through a caspase-dependent pathwaySonja Katharina Königs, Christian Philipp Pallasch, Lars Hartwin Lindner, et al.
American Journal of Hematology|May 29, 2021
Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trialOthman Al-Sawaf, Brittany Gentile, Jacob Devine, et al.
Blood|August 15, 2002
Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectorsClemens-Martin Wendtner, David M Kofler, Hans D Theiss, et al.
Blood|February 12, 2015
miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLLValeska Berg, Marion Rusch, Nachiket Vartak, et al.
Leukemia & Lymphoma|July 1, 2016
FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemiaNadine Kutsch, Raymonde Busch, Jasmin Bahlo, et al.
Blood|August 24, 2012
A novel hierarchical prognostic model of AML solely based on molecular mutationsVera Grossmann, Susanne Schnittger, Alexander Kohlmann, et al.
Pageof 11